Clinical Perspectives

Researchers Investigating TIL Therapy Feasibility in Head and Neck Squamous Cell Cancer

Dr. Kedar Kirtane is the principal investigator for a Phase IB clinical trial focusing on Squamous Cell Cancer Tumor-Infiltrating Lymphocytes (TIL).

How a CRC Enhances the Patient’s Journey at Moffitt

Clinical research coordinators at Moffitt are essential pillars in executing clinical trials.

FDA Approves CARVYKTI® and ABECMA for Early Treatment of Adult Patients with Relapsed or Refractory Multiple Myeloma

On April 5, 2024, the FDA revised the indications of both approved CAR T cell therapies for relapsed multiple myeloma to allow the use of these...

Advancements in Non-Muscle Invasive Bladder Cancer Treatment

The FDA has approved many alternative treatment methods for NMIBC, and several others are being investigated in clinical efficacy trials.

Pioneering Advances in Upper Extremity Oncologic Reconstruction and Endoprosthetic Reverse Shoulder Technology

Reverse shoulder technology is a new, promising solution that allows for improved shoulder function. At Moffitt, patients have access to a leading...

Advancements in Pancreatic Cancer Vaccines: A New Frontier in Immunotherapy Treatment

The landscape of pancreatic cancer treatment is evolving, driven by innovative approaches such as immunotherapy and pancreatic cancer vaccines.

FAQ: Revolutionizing Radiation Treatment with Proton Therapy

Moffitt is excited to partner with IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, to bring proton...

Revolutionizing Thyroid Surgeries with Autofluorescence Technology

A groundbreaking innovation leading the charge in improving surgical outcomes for thyroid and parathyroid surgeries is autofluorescence technology.

Revolutionizing Melanoma Treatment: FDA Approval for TILs Therapy Marks a Turning Point

The recent FDA approval of Lifileucel TIL therapy presents a groundbreaking advancement in the realm of solid tumor cancer treatment.

Navigating New Frontiers: Far Medial Technique in Minimally Invasive Brain Tumor Surgery

For lesions requiring surgery in the clivus region, navigating these intricate structures near the base of the brain requires high precision.

Moffitt's CARDIO-CATCH Clinic for Clonal Hematopoiesis

With a strong commitment to understanding and addressing the implications of clonal hematopoiesis mutations, Moffitt is pioneering a groundbreaking...

Leaders in the Use of Navigated Bone Tumor Resections and Custom Implant Reconstruction

Increasing research demonstrates that navigated resections, especially in complicated locations like the pelvis, can improve cancer-specific...

Advancements in Robotic Surgery for Radical Stump Trachelectomy

A radical stump trachelectomy is the removal of the cervix and not the uterus using a minimally invasive surgery technique.

One of Only Five Multidisciplinary Cutaneous Lymphoma Clinics in U.S. is at Moffitt

Cutaneous lymphomas are a heterogenous group of lymphoproliferative disorders that present in the skin and are composed of malignant clonal T- or...

Your Vote Counts! U.S. News Physician Survey is Underway

The U.S News physician survey is underway—and at Moffitt we understand the importance of an expert opinion. We encourage all our fellow providers to...